Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Condensed Consolidated Statements of Operations and Comprehensive Loss
Collaboration revenue	$ 0	$ 2,926
Operating expenses:
Research and development	46,381	36,872
General and administrative	12,950	10,690
Total operating expenses	59,331	47,562
Loss from operations	(59,331)	(44,636)
Interest income	5,492	2,996
Net loss	$ (53,839)	$ (41,640)
Per share information:
Net loss per share, basic	$ (0.48)	$ (0.52)
Net loss per share, diluted	$ (0.48)	$ (0.52)
Weighted-average shares outstanding, basic	113,136,836	79,410,354
Weighted-average shares outstanding, diluted	113,136,836	79,410,354
Comprehensive loss:
Net loss	$ (53,839)	$ (41,640)
Unrealized loss on marketable securities	(0)	(60)
Comprehensive loss	$ (53,839)	$ (41,700)